Influence of Artefact Correction and Recording Device Type on the Practical Application of a Non-Linear Heart Rate Variability Biomarker for Aerobic Threshold Determination.

aerobic threshold artefact detrended fluctuation analysis endurance exercise heart rate monitors heart rate variability intensity distribution ventilatory threshold wearables

Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
26 Jan 2021
Historique:
received: 19 12 2020
revised: 13 01 2021
accepted: 22 01 2021
entrez: 3 2 2021
pubmed: 4 2 2021
medline: 28 4 2021
Statut: epublish

Résumé

Recent study points to the value of a non-linear heart rate variability (HRV) biomarker using detrended fluctuation analysis (DFA a1) for aerobic threshold determination (HRVT). Significance of recording artefact, correction methods and device bias on DFA a1 during exercise and HRVT is unclear. Gas exchange and HRV data were obtained from 17 participants during an incremental treadmill run using both ECG and Polar H7 as recording devices. First, artefacts were randomly placed in the ECG time series to equal 1, 3 and 6% missed beats with correction by Kubios software's automatic and medium threshold method. Based on linear regression, Bland Altman analysis and Wilcoxon paired testing, there was bias present with increasing artefact quantity. Regardless of artefact correction method, 1 to 3% missed beat artefact introduced small but discernible bias in raw DFA a1 measurements. At 6% artefact using medium correction, proportional bias was found (maximum 19%). Despite this bias, the mean HRVT determination was within 1 bpm across all artefact levels and correction modalities. Second, the HRVT ascertained from synchronous ECG vs. Polar H7 recordings did show an average bias of minus 4 bpm. Polar H7 results suggest that device related bias is possible but in the reverse direction as artefact related bias.

Identifiants

pubmed: 33530473
pii: s21030821
doi: 10.3390/s21030821
pmc: PMC7865269
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Braz J Phys Ther. 2018 Sep - Oct;22(5):383-390
pubmed: 29653903
Ann Noninvasive Electrocardiol. 2018 Jan;23(1):
pubmed: 28670841
Am J Cardiol. 2019 May 15;123(10):1643-1648
pubmed: 30878151
Clin Exp Pharmacol Physiol. 2010 Feb;37(2):143-9
pubmed: 19719745
Res Sports Med. 2019 Jan-Mar;27(1):88-98
pubmed: 30040499
Front Physiol. 2012 May 23;3:148
pubmed: 22654764
J Strength Cond Res. 2018 Mar;32(3):726-735
pubmed: 29466273
Med Sci Sports Exerc. 2001 Nov;33(11):1841-8
pubmed: 11689733
Int J Sports Med. 2006 Oct;27(10):780-5
pubmed: 16586334
IEEE Trans Biomed Eng. 1985 Mar;32(3):230-6
pubmed: 3997178
Chaos. 1995;5(1):82-7
pubmed: 11538314
Front Physiol. 2017 May 29;8:301
pubmed: 28611675
Eur J Appl Physiol. 2019 Jul;119(7):1525-1532
pubmed: 31004219
Clin Physiol Funct Imaging. 2003 Jul;23(4):215-23
pubmed: 12914561
Front Physiol. 2019 Aug 02;10:999
pubmed: 31427992
Int J Sports Med. 2005 Jan-Feb;26(1):39-44
pubmed: 15643533
J Electrocardiol. 1995;28 Suppl:65-70
pubmed: 8656131
Front Physiol. 2021 Jan 15;11:596567
pubmed: 33519504
Front Physiol. 2014 Feb 27;5:73
pubmed: 24578692
PLoS One. 2018 Apr 19;13(4):e0195894
pubmed: 29672555
Australas Phys Eng Sci Med. 2017 Dec;40(4):831-839
pubmed: 29058222
Ann Noninvasive Electrocardiol. 2020 Jan;25(1):e12697
pubmed: 31498541
Singapore Med J. 2003 Dec;44(12):614-9
pubmed: 14770254
J Appl Physiol (1985). 2018 Mar 01;124(3):646-652
pubmed: 28935830
Pacing Clin Electrophysiol. 2009 Jan;32(1):43-51
pubmed: 19140912
Cardiovasc Diagn Ther. 2019 Aug;9(4):379-385
pubmed: 31555543
Stat Methods Med Res. 1999 Jun;8(2):135-60
pubmed: 10501650
Int J Sports Physiol Perform. 2017 Nov 1;12(10):1324-1328
pubmed: 28290720
Psychophysiology. 1998 Jan;35(1):127-32
pubmed: 9499713
J Clin Med. 2020 Jan 23;9(2):
pubmed: 31979367
Ann Noninvasive Electrocardiol. 2004 Apr;9(2):127-35
pubmed: 15084209
Bioengineering (Basel). 2020 Jun 06;7(2):
pubmed: 32517214
J Med Eng Technol. 2019 Apr;43(3):173-181
pubmed: 31314618
Front Physiol. 2020 Sep 18;11:550572
pubmed: 33071812
Diagnostics (Basel). 2020 May 22;10(5):
pubmed: 32456091
Hum Mov Sci. 2018 Aug;60:225-233
pubmed: 29966866
Comput Methods Programs Biomed. 2014;113(1):210-20
pubmed: 24054542
J Clin Med. 2019 Feb 06;8(2):
pubmed: 30736284
Eur J Appl Physiol. 2018 Mar;118(3):669-677
pubmed: 29356949

Auteurs

Bruce Rogers (B)

College of Medicine, University of Central Florida, 6850 Lake Nona Boulevard, Orlando, FL 32827-7408, USA.

David Giles (D)

Lattice Training Ltd., Chesterfield S41 9AT, UK.

Nick Draper (N)

School of Health Sciences, College of Education, Health and Human Development, University of Canterbury, Christchurch 8041, New Zealand.

Laurent Mourot (L)

EA3920 Prognostic Factors and Regulatory Factors of Cardiac and Vascular Pathologies, Exercise Performance Health Innovation (EPHI) Platform, University of Bourgogne Franche-Comté, 25000 Besançon, France.
Division for Physical Education, National Research Tomsk Polytechnic University, Lenin Ave, 30, 634050 Tomsk Oblast, Russia.

Thomas Gronwald (T)

Department of Performance, Neuroscience, Therapy and Health, MSH Medical School Hamburg, Faculty of Health Sciences, University of Applied Sciences and Medical University, Am Kaiserkai 1, 20457 Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH